Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina
Rituximab is an effective treatment in patients with established rheumatoid arthritis (RA). The objective of the IMAGE study was to determine the efficacy of rituximab in the prevention of joint damage and its safety in combination with methotrexate (MTX) in patients initiating treatment with MTX.
Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial / Tak, Pp; Rigby, Wf; Rubbert Roth, A; Peterfy, Cg; van Vollenhoven, Rf; Stohl, W; Hessey, E; Chen, A; Tyrrell, H; Shaw, Tm; Aelion J, IMAGE I. n. v. e. s. t. i. g. a. t. o. r. s.; Afif, N; Ahmadi, F; Aires, F; Alanis, E; Alonso, Cs; Alten, Rh; Alvaro Gracia, Jm; Ashrafzadeh, A; Ballina, J; Bambara, Lm; Bao, C; Bell, M; Berney, S; Bessette, L; Birbara, C; Boling, E; Bourgeois, P; Braun, J; Briones, H; Brzezicki, J; Burgos Vargos, R; Burmester, G; Burnett, M; Busch, H; Cabello, E; Calvo, A; Cantagrel, A; Cantini, F; Zea, Ac; Carreño Perez, L; Chavez, J; Shim, Sc; Chindalore, V; Chiriac, R; Codding, C; Danda, D; Del Guidice, J; De Vita, S; Digiovanni, R; Dikranian, A; Eider, W; Fantini, F; Ferraccioli, G; Fietchner, J; Filipowicz Sosnowska, A; Finnanger, B; Fiocco, G; Fleck, M; Fleischmann, R; Fraser, A; Gaudin, P; Gauler, G; Gaylis, N; Gerlag, Dm; Godde, J; Gomez Reino, Jj; Gornisiewicz, M; Gough, W; Greenwald, M; Guerra, G; Hackshaw, K; Haentzschel, Hm; Hammond, T; Hazleman, Bl; Heilig, B; Herenius, Mm; Hilliquin, P; Holt, D; Huang, F; Huff, J; Huizinga, T; Isaacs, J; Jaffer, A; Amante, Ej; Jeka, S; Jimenez, R; Jones, G; Jones, R; Kaine, J; Kashif, A; Kaufmann, C; Kay, J; Khraishi, M; Kivitz, A; Klinkhoff, A; Kraag, G; Krystufkova, O; Kucharz, E; Lawson, J; Leirisalo Repo, M; Levin, R; Liang, G; Liang, P; Limonta, M; Lowenstein, M; Rodriguez Lozano, C; Lue, C; Mahowald, M; Maradiaga, M; Maricic, M; Mariette, X; Martin, L; Massarotti, E; Matucci Cerinic, M; Montecucco, Cm; Mazurov, V; Mcnally, J; Mehta, D; Meyer, O; Misra, R; Moreland, Lw; Mueller Ladner, U; Myerson, G; Nasonov, E; Navarra, S; Navarro, F; Neal, N; Olech, E; Olsen, N; Pablos, Jl; Pacheco, C; Pal, S; Palomo, Er; Pandith, V; Penserga, Eg; Prupas, H; Radominski, S; Ramos Remus, C; Reid, D; Riordan, K; Rosenberg, D; Ruiz, A; Saadeh, C; Salvarani, Carlo; Samuels, A; Sanmarti, R; Sarzi Puttini, P; Saxe, P; Schechtman, J; Scoville, C; Sedlackova, M; Sedrish, M; Sejer Hansen, M; Sibilia, J; Siebert, S; Specker, C; Stern, S; Szechinski, J; Tahir, H; Taylor, A; Thompson, Pw; Tony, Hp; Tornero, J; Trapp, R; Tremblay, Jl; Valesini, G; Van Den Bosch, F; Wanchu, A; Wassenberg, S; Ximenes, Ac; Kim, Hy; Zanetakis, E; Zazueta, B; Zerbini, C.. - In: ANNALS OF THE RHEUMATIC DISEASES. - ISSN 0003-4967. - 70:1(2011), pp. 39-46. [10.1136/ard.2010.137703]
Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial.
Rituximab is an effective treatment in patients with established rheumatoid arthritis (RA). The objective of the IMAGE study was to determine the efficacy of rituximab in the prevention of joint damage and its safety in combination with methotrexate (MTX) in patients initiating treatment with MTX.
Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1078950
Citazioni
70
251
229
social impact
Conferma cancellazione
Sei sicuro che questo prodotto debba essere cancellato?
simulazione ASN
La simulazione può differire dall'esito di un’eventuale domanda ASN sia per errori di catalogazione e/o dati mancanti in IRIS, sia per la variabilità dei dati bibliometrici nel tempo. L’Università di Modena e Reggio Emilia non si assume alcuna responsabilità in merito all’uso che il diretto interessato o terzi faranno della simulazione.